Cargando…
OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study
PURPOSE: Obesity, the state of excessive adipose tissue, with increased morbidity, mortality from numerous diseases nearly in a pandemic stage; necessitates urgent search for safe, effective anti-obesity medications, as extant modern drugs have significant major adverse effects. Charaka elaborated v...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800890/ |
_version_ | 1782288049839800320 |
---|---|
author | Wagh, Madhuri Hemant |
author_facet | Wagh, Madhuri Hemant |
author_sort | Wagh, Madhuri Hemant |
collection | PubMed |
description | PURPOSE: Obesity, the state of excessive adipose tissue, with increased morbidity, mortality from numerous diseases nearly in a pandemic stage; necessitates urgent search for safe, effective anti-obesity medications, as extant modern drugs have significant major adverse effects. Charaka elaborated very lucidly qualitative signs & symptoms of obesity (Sutrasthan A21). Gorakhmundi (Sphaeranthus indicus), a widely available seasonal wild herb, called Som-Sum-Veerya (Sushruta), Palankash (weathers fat away; Shaligram), Mundi (beheads diseases), anti-obesity effects mentioned in seven Nighantu(s); thus holds promise. This study evaluates its anti-obesity efficacy using single-blind, placebo-controlled design. METHOD: Forty persons (age 25-50 yrs), 20 each in study and control groups, with weight >10kg excess than LIC actuarial mean normal, evaluated at baseline using BMI, Waist/Hip Ratio, skin-fold thickness at Biceps, Triceps, Sub-scapular & Supra-iliac sites and also 23 qualitative criteria collated from Ayurveda's Classical Texts; were administered for 90 days at 2gm/day dose either Gorakhmundi Panchang-Choorna or Spinach Choorna respectively and reassessed monthly. Anthropometric measurements analysed using descriptive statistics & paired t test. Qualitative criteria- descriptive statistics. RESULT: At 90 days, Study Group shows >5% weight reduction in 45%, 35% in 45%, 0.334/week or 1.34/month, Highly Significant weight reduction, p<0.001, Improvement in BMI, p<0.001; W/H Ratio, p<0.001; Skin-fold Triceps, Subscapular, Suprailiac, p<0.001, (Biceps p<0.05), Qualitative features viz. Body Malodor, Hyper-sweating, heaviness, slackness, lack of swiftness, laziness, exercise intolerance, deep breathing discomfort, excessive thirst showed considerable improvement in majority persons showing these at baseline. CONCLUSION: Study confirms Gorakhmundi's significant anti-obesity efficacy, using single blind placebo-control design and modest sample. |
format | Online Article Text |
id | pubmed-3800890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-38008902013-10-25 OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study Wagh, Madhuri Hemant Anc Sci Life Oral Presentation PURPOSE: Obesity, the state of excessive adipose tissue, with increased morbidity, mortality from numerous diseases nearly in a pandemic stage; necessitates urgent search for safe, effective anti-obesity medications, as extant modern drugs have significant major adverse effects. Charaka elaborated very lucidly qualitative signs & symptoms of obesity (Sutrasthan A21). Gorakhmundi (Sphaeranthus indicus), a widely available seasonal wild herb, called Som-Sum-Veerya (Sushruta), Palankash (weathers fat away; Shaligram), Mundi (beheads diseases), anti-obesity effects mentioned in seven Nighantu(s); thus holds promise. This study evaluates its anti-obesity efficacy using single-blind, placebo-controlled design. METHOD: Forty persons (age 25-50 yrs), 20 each in study and control groups, with weight >10kg excess than LIC actuarial mean normal, evaluated at baseline using BMI, Waist/Hip Ratio, skin-fold thickness at Biceps, Triceps, Sub-scapular & Supra-iliac sites and also 23 qualitative criteria collated from Ayurveda's Classical Texts; were administered for 90 days at 2gm/day dose either Gorakhmundi Panchang-Choorna or Spinach Choorna respectively and reassessed monthly. Anthropometric measurements analysed using descriptive statistics & paired t test. Qualitative criteria- descriptive statistics. RESULT: At 90 days, Study Group shows >5% weight reduction in 45%, 35% in 45%, 0.334/week or 1.34/month, Highly Significant weight reduction, p<0.001, Improvement in BMI, p<0.001; W/H Ratio, p<0.001; Skin-fold Triceps, Subscapular, Suprailiac, p<0.001, (Biceps p<0.05), Qualitative features viz. Body Malodor, Hyper-sweating, heaviness, slackness, lack of swiftness, laziness, exercise intolerance, deep breathing discomfort, excessive thirst showed considerable improvement in majority persons showing these at baseline. CONCLUSION: Study confirms Gorakhmundi's significant anti-obesity efficacy, using single blind placebo-control design and modest sample. Medknow Publications & Media Pvt Ltd 2012-12 /pmc/articles/PMC3800890/ Text en Copyright: © 2012 Madhuri Hemant Wagh; licensee Ancient Science of Life. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Presentation Wagh, Madhuri Hemant OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study |
title | OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study |
title_full | OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study |
title_fullStr | OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study |
title_full_unstemmed | OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study |
title_short | OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study |
title_sort | oa01.14. efficacy of gorakhmundi in obesity: a single-blind placebo-controlled study |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800890/ |
work_keys_str_mv | AT waghmadhurihemant oa0114efficacyofgorakhmundiinobesityasingleblindplacebocontrolledstudy AT oa0114efficacyofgorakhmundiinobesityasingleblindplacebocontrolledstudy |